The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Estrogen and Progesterone Market Research Report 2025

Global Estrogen and Progesterone Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1553673

No of Pages : 104

Ask Your Query

Synopsis

Progesterone and estrogen are the two most important hormones in the female body. These are steroid hormones that are responsible for various female characteristics in the body.

The global Estrogen and Progesterone market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North American market for Estrogen and Progesterone is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Estrogen and Progesterone is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Estrogen and Progesterone include Gedeon Richter, Bayer, N.V.Organon, Pfizer Healthcare, Jenapharm, Besins Healthcare, MERCK SERONO, Abbott and Teva Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Estrogen and Progesterone, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Estrogen and Progesterone.

Report Scope

The Estrogen and Progesterone market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Estrogen and Progesterone market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Estrogen and Progesterone manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • Gedeon Richter
  • Bayer
  • N.V.Organon
  • Pfizer Healthcare
  • Jenapharm
  • Besins Healthcare
  • MERCK SERONO
  • Abbott
  • Teva Pharma
  • Aspen Pharmacare
  • Dr.Kade Pharmazeutische Fabrik
  • F.I.S.-FABBRICA
  • Eli Lilly
  • Orion
  • AstraZeneca
  • Novartis Pharma
  • Novo Nordisk

Segment by Type

  • Estrogen
  • Progesterone

Segment by Application

  • Pharmacy
  • Hospital
  • Department of Endocrinology

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Estrogen and Progesterone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Estrogen and Progesterone in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Index

1 Estrogen and Progesterone Market Overview
1.1 Product Overview and Scope of Estrogen and Progesterone
1.2 Estrogen and Progesterone Segment by Type
1.2.1 Global Estrogen and Progesterone Market Value Comparison by Type (2024-2030)
1.2.2 Estrogen
1.2.3 Progesterone
1.3 Estrogen and Progesterone Segment by Application
1.3.1 Global Estrogen and Progesterone Market Value by Application: (2024-2030)
1.3.2 Pharmacy
1.3.3 Hospital
1.3.4 Department of Endocrinology
1.4 Global Estrogen and Progesterone Market Size Estimates and Forecasts
1.4.1 Global Estrogen and Progesterone Revenue 2019-2030
1.4.2 Global Estrogen and Progesterone Sales 2019-2030
1.4.3 Global Estrogen and Progesterone Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Estrogen and Progesterone Market Competition by Manufacturers
2.1 Global Estrogen and Progesterone Sales Market Share by Manufacturers (2019-2024)
2.2 Global Estrogen and Progesterone Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Estrogen and Progesterone Average Price by Manufacturers (2019-2024)
2.4 Global Estrogen and Progesterone Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Estrogen and Progesterone, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Estrogen and Progesterone, Product Type & Application
2.7 Estrogen and Progesterone Market Competitive Situation and Trends
2.7.1 Estrogen and Progesterone Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Estrogen and Progesterone Players Market Share by Revenue
2.7.3 Global Estrogen and Progesterone Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Estrogen and Progesterone Retrospective Market Scenario by Region
3.1 Global Estrogen and Progesterone Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Estrogen and Progesterone Global Estrogen and Progesterone Sales by Region: 2019-2030
3.2.1 Global Estrogen and Progesterone Sales by Region: 2019-2024
3.2.2 Global Estrogen and Progesterone Sales by Region: 2025-2030
3.3 Global Estrogen and Progesterone Global Estrogen and Progesterone Revenue by Region: 2019-2030
3.3.1 Global Estrogen and Progesterone Revenue by Region: 2019-2024
3.3.2 Global Estrogen and Progesterone Revenue by Region: 2025-2030
3.4 North America Estrogen and Progesterone Market Facts & Figures by Country
3.4.1 North America Estrogen and Progesterone Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Estrogen and Progesterone Sales by Country (2019-2030)
3.4.3 North America Estrogen and Progesterone Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Estrogen and Progesterone Market Facts & Figures by Country
3.5.1 Europe Estrogen and Progesterone Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Estrogen and Progesterone Sales by Country (2019-2030)
3.5.3 Europe Estrogen and Progesterone Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Estrogen and Progesterone Market Facts & Figures by Country
3.6.1 Asia Pacific Estrogen and Progesterone Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Estrogen and Progesterone Sales by Country (2019-2030)
3.6.3 Asia Pacific Estrogen and Progesterone Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Estrogen and Progesterone Market Facts & Figures by Country
3.7.1 Latin America Estrogen and Progesterone Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Estrogen and Progesterone Sales by Country (2019-2030)
3.7.3 Latin America Estrogen and Progesterone Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Estrogen and Progesterone Market Facts & Figures by Country
3.8.1 Middle East and Africa Estrogen and Progesterone Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Estrogen and Progesterone Sales by Country (2019-2030)
3.8.3 Middle East and Africa Estrogen and Progesterone Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Estrogen and Progesterone Sales by Type (2019-2030)
4.1.1 Global Estrogen and Progesterone Sales by Type (2019-2024)
4.1.2 Global Estrogen and Progesterone Sales by Type (2025-2030)
4.1.3 Global Estrogen and Progesterone Sales Market Share by Type (2019-2030)
4.2 Global Estrogen and Progesterone Revenue by Type (2019-2030)
4.2.1 Global Estrogen and Progesterone Revenue by Type (2019-2024)
4.2.2 Global Estrogen and Progesterone Revenue by Type (2025-2030)
4.2.3 Global Estrogen and Progesterone Revenue Market Share by Type (2019-2030)
4.3 Global Estrogen and Progesterone Price by Type (2019-2030)
5 Segment by Application
5.1 Global Estrogen and Progesterone Sales by Application (2019-2030)
5.1.1 Global Estrogen and Progesterone Sales by Application (2019-2024)
5.1.2 Global Estrogen and Progesterone Sales by Application (2025-2030)
5.1.3 Global Estrogen and Progesterone Sales Market Share by Application (2019-2030)
5.2 Global Estrogen and Progesterone Revenue by Application (2019-2030)
5.2.1 Global Estrogen and Progesterone Revenue by Application (2019-2024)
5.2.2 Global Estrogen and Progesterone Revenue by Application (2025-2030)
5.2.3 Global Estrogen and Progesterone Revenue Market Share by Application (2019-2030)
5.3 Global Estrogen and Progesterone Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Gedeon Richter
6.1.1 Gedeon Richter Corporation Information
6.1.2 Gedeon Richter Description and Business Overview
6.1.3 Gedeon Richter Estrogen and Progesterone Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Gedeon Richter Estrogen and Progesterone Product Portfolio
6.1.5 Gedeon Richter Recent Developments/Updates
6.2 Bayer
6.2.1 Bayer Corporation Information
6.2.2 Bayer Description and Business Overview
6.2.3 Bayer Estrogen and Progesterone Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Bayer Estrogen and Progesterone Product Portfolio
6.2.5 Bayer Recent Developments/Updates
6.3 N.V.Organon
6.3.1 N.V.Organon Corporation Information
6.3.2 N.V.Organon Description and Business Overview
6.3.3 N.V.Organon Estrogen and Progesterone Sales, Revenue and Gross Margin (2019-2024)
6.3.4 N.V.Organon Estrogen and Progesterone Product Portfolio
6.3.5 N.V.Organon Recent Developments/Updates
6.4 Pfizer Healthcare
6.4.1 Pfizer Healthcare Corporation Information
6.4.2 Pfizer Healthcare Description and Business Overview
6.4.3 Pfizer Healthcare Estrogen and Progesterone Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Pfizer Healthcare Estrogen and Progesterone Product Portfolio
6.4.5 Pfizer Healthcare Recent Developments/Updates
6.5 Jenapharm
6.5.1 Jenapharm Corporation Information
6.5.2 Jenapharm Description and Business Overview
6.5.3 Jenapharm Estrogen and Progesterone Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Jenapharm Estrogen and Progesterone Product Portfolio
6.5.5 Jenapharm Recent Developments/Updates
6.6 Besins Healthcare
6.6.1 Besins Healthcare Corporation Information
6.6.2 Besins Healthcare Description and Business Overview
6.6.3 Besins Healthcare Estrogen and Progesterone Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Besins Healthcare Estrogen and Progesterone Product Portfolio
6.6.5 Besins Healthcare Recent Developments/Updates
6.7 MERCK SERONO
6.6.1 MERCK SERONO Corporation Information
6.6.2 MERCK SERONO Description and Business Overview
6.6.3 MERCK SERONO Estrogen and Progesterone Sales, Revenue and Gross Margin (2019-2024)
6.4.4 MERCK SERONO Estrogen and Progesterone Product Portfolio
6.7.5 MERCK SERONO Recent Developments/Updates
6.8 Abbott
6.8.1 Abbott Corporation Information
6.8.2 Abbott Description and Business Overview
6.8.3 Abbott Estrogen and Progesterone Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Abbott Estrogen and Progesterone Product Portfolio
6.8.5 Abbott Recent Developments/Updates
6.9 Teva Pharma
6.9.1 Teva Pharma Corporation Information
6.9.2 Teva Pharma Description and Business Overview
6.9.3 Teva Pharma Estrogen and Progesterone Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Teva Pharma Estrogen and Progesterone Product Portfolio
6.9.5 Teva Pharma Recent Developments/Updates
6.10 Aspen Pharmacare
6.10.1 Aspen Pharmacare Corporation Information
6.10.2 Aspen Pharmacare Description and Business Overview
6.10.3 Aspen Pharmacare Estrogen and Progesterone Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Aspen Pharmacare Estrogen and Progesterone Product Portfolio
6.10.5 Aspen Pharmacare Recent Developments/Updates
6.11 Dr.Kade Pharmazeutische Fabrik
6.11.1 Dr.Kade Pharmazeutische Fabrik Corporation Information
6.11.2 Dr.Kade Pharmazeutische Fabrik Estrogen and Progesterone Description and Business Overview
6.11.3 Dr.Kade Pharmazeutische Fabrik Estrogen and Progesterone Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Dr.Kade Pharmazeutische Fabrik Estrogen and Progesterone Product Portfolio
6.11.5 Dr.Kade Pharmazeutische Fabrik Recent Developments/Updates
6.12 F.I.S.-FABBRICA
6.12.1 F.I.S.-FABBRICA Corporation Information
6.12.2 F.I.S.-FABBRICA Estrogen and Progesterone Description and Business Overview
6.12.3 F.I.S.-FABBRICA Estrogen and Progesterone Sales, Revenue and Gross Margin (2019-2024)
6.12.4 F.I.S.-FABBRICA Estrogen and Progesterone Product Portfolio
6.12.5 F.I.S.-FABBRICA Recent Developments/Updates
6.13 Eli Lilly
6.13.1 Eli Lilly Corporation Information
6.13.2 Eli Lilly Estrogen and Progesterone Description and Business Overview
6.13.3 Eli Lilly Estrogen and Progesterone Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Eli Lilly Estrogen and Progesterone Product Portfolio
6.13.5 Eli Lilly Recent Developments/Updates
6.14 Orion
6.14.1 Orion Corporation Information
6.14.2 Orion Estrogen and Progesterone Description and Business Overview
6.14.3 Orion Estrogen and Progesterone Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Orion Estrogen and Progesterone Product Portfolio
6.14.5 Orion Recent Developments/Updates
6.15 AstraZeneca
6.15.1 AstraZeneca Corporation Information
6.15.2 AstraZeneca Estrogen and Progesterone Description and Business Overview
6.15.3 AstraZeneca Estrogen and Progesterone Sales, Revenue and Gross Margin (2019-2024)
6.15.4 AstraZeneca Estrogen and Progesterone Product Portfolio
6.15.5 AstraZeneca Recent Developments/Updates
6.16 Novartis Pharma
6.16.1 Novartis Pharma Corporation Information
6.16.2 Novartis Pharma Estrogen and Progesterone Description and Business Overview
6.16.3 Novartis Pharma Estrogen and Progesterone Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Novartis Pharma Estrogen and Progesterone Product Portfolio
6.16.5 Novartis Pharma Recent Developments/Updates
6.17 Novo Nordisk
6.17.1 Novo Nordisk Corporation Information
6.17.2 Novo Nordisk Estrogen and Progesterone Description and Business Overview
6.17.3 Novo Nordisk Estrogen and Progesterone Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Novo Nordisk Estrogen and Progesterone Product Portfolio
6.17.5 Novo Nordisk Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Estrogen and Progesterone Industry Chain Analysis
7.2 Estrogen and Progesterone Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Estrogen and Progesterone Production Mode & Process
7.4 Estrogen and Progesterone Sales and Marketing
7.4.1 Estrogen and Progesterone Sales Channels
7.4.2 Estrogen and Progesterone Distributors
7.5 Estrogen and Progesterone Customers
8 Estrogen and Progesterone Market Dynamics
8.1 Estrogen and Progesterone Industry Trends
8.2 Estrogen and Progesterone Market Drivers
8.3 Estrogen and Progesterone Market Challenges
8.4 Estrogen and Progesterone Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock